1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3 Purity >98.0% (HPLC) Brexpiprazole Intermediate Factory

Incazelo emfushane:

1-(1-Benzothiophen-4-yl)piperazine Hydrochloride

I-CAS: 913614-18-3

Ubumsulwa: >99.0% (HPLC)

Ukubukeka: Impushana Emhlophe ukuya Emhlophe

I-Intermediate ye-Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Chemical Properties:

Igama Lekhemikhali 1-(1-Benzothiophen-4-yl)piperazine Hydrochloride
Omqondofana I-Brexpiprazole Ephakathi 2;I-1-Benzo[b]thien-4-yl-Piperazine Hydrochloride;I-1-Benzo[b]thien-4-ylpiperazine Monohydrochloride
Inombolo ye-CAS 913614-18-3
Inombolo yeCAT I-RF-PI1034
Isimo Sesitoko Esitokweni, Amandla Okukhiqiza 100MT/Ngonyaka
I-Molecular Formula I-C12H15ClN2S
Isisindo samangqamuzana 254.7789
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Emhlophe Kuya Kumhlophe
Ukuhlonza Isikhathi sokugcinwa kwesampula sihambisana naleso sezinga lesithenjwa
Ukuhlanzeka / Indlela Yokuhlaziya >99.0% (HPLC)
Ukulahlekelwa Ekumisweni <0.50%
Amanzi (KF) <0.50%
Izinsalela Ekushiseni <0.20%
Izinto Ezihlobene (HPLC)
Noma yikuphi Ukungcola Komuntu Ngamunye <0.50%
Ukungcola Okuphelele <1.00%
I-Infrared Spectrum Ivumelana Nesakhiwo
I-Proton NMR Spectrum Ivumelana Nesakhiwo
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Intermediate ye-Brexpiprazole (CAS: 913611-97-9)

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

1

I-FAQ:

Isicelo:

I-1-(1-Benzothiophen-4-yl)piperazine Hydrochloride (CAS: 913614-18-3) iphakathi kwe-Brexpiprazole (CAS: 913611-97-9).I-Brexpiprazole iwuhlobo lwe-atypical antipsychotic.Kuyi-dopamine D2 receptor partial agonist.Njengenoveli ye-serotonin-dopamine modulator yomsebenzi, ingasetshenziselwa ukwelapha i-schizophrenia, kanye nokwelashwa okuhlanganisayo kokudangala.Ingase futhi inikeze ukusebenza kahle kanye nokubekezelelana phezu kokwelashwa okuhlanganisiwe okusungulwe i-formajor depressive disorder(MDD).Isidakamizwa sibonisa iphrofayili ye-pharmacological eyingqayizivele, esebenza njenge-agonist ingxenye ye-serotonin 5-HT1A kanye ne-dopamine D2 receptors futhi njengomphikisi ogcwele we-5-HT2A kanye ne-noradrenaline α1B / 2C receptors, enobudlelwane obubophezelayo obufanayo be-subnanomolar.Umuthi, owakhiwa u-Otsuka kanye no-Lundbeck, wagunyazwa ngo-2015 yi-FDA ukuze welaphe i-schizophrenia kanye nokwelapha okuhlanganisa nokudangala.

Bhala umyalezo wakho lapha futhi usithumelele wona